Hesham Hamed

Chief Scientific Officer (CSO), Co-Founder and Board Member at Adoram Therapeutics - Lancy, Geneva, Switzerland

Hesham Hamed's Colleagues at Adoram Therapeutics
Hesham Hamed's Contact Details
HQ
Location
Geneva,Geneva,Switzerland
Company
Adoram Therapeutics
Hesham Hamed's Company Details
Adoram Therapeutics logo, Adoram Therapeutics contact details

Adoram Therapeutics

Lancy, Geneva, Switzerland • 2 Employees
Biotechnology

Adoram Therapeutics is developing a suite of therapies with an allosteric molecular mode of action, which can either positively or negatively modulate the signaling of specific GPCRs - the largest class of human receptors. Our foremost asset is a small molecule immunotherapy to treat patients with solid tumors. Thanks to its unique allosteric mode of action, this 3rd generation adenosine 2A receptor antagonist retains its potency in high adenosine (immunosuppressive) microenvironments, such as those found in many solid tumors, and is therefore intended to be used as a treatment for a wide range of cancers.

Details about Adoram Therapeutics
Frequently Asked Questions about Hesham Hamed
Hesham Hamed currently works for Adoram Therapeutics.
Hesham Hamed's role at Adoram Therapeutics is Chief Scientific Officer (CSO), Co-Founder and Board Member.
Hesham Hamed's email address is ***@skyhawktx.com. To view Hesham Hamed's full email address, please signup to ConnectPlex.
Hesham Hamed works in the Biotechnology industry.
Hesham Hamed's colleagues at Adoram Therapeutics are David Pejoski and others.
Hesham Hamed's phone number is
See more information about Hesham Hamed